Results 211 to 220 of about 101,544 (308)

Respiratory safety of lemborexant in adult and elderly subjects with moderate‐to‐severe chronic obstructive pulmonary disease

open access: yesJournal of Sleep Research, Volume 34, Issue 2, April 2025.
Lemborexant 10 mg, a dual orexin‐receptor antagonist (DORA), did not elicit respiratory depressant effects, as measured by peripheral oxygen saturation (SpO2) or apnea–hypopnea index (AHI), in subjects with moderate‐to‐severe chronic obstructive pulmonary disease (COPD).
Jocelyn Y. Cheng   +3 more
wiley   +1 more source

Determination of some characteristic of alfalfa populations collected in Ahi Evran University campus

open access: yes, 2017
Bu çalışmada Ahi Evran Üniversitesi meralarından 2014 yılında toplanan 51 yonca (Medicago sativa L.) populasyonlarına ait tohumlar kullanılmıştır.
Nehir, Mahmut Ferhat
core  

Phenotypic Variability in Slow‐Wave Sleep in Depression: Associations With Clinical Profiles and Disorder Severity

open access: yesJournal of Sleep Research, EarlyView.
ABSTRACT Slow‐wave sleep (SWS; stage N3) is often reported as reduced in depression, yet variability across depressive phenotypes remains poorly characterised. This study aimed to determine whether N3 architecture—proportion, duration, and latency—identifies clinically distinct profiles in major depressive episode (MDE).
Antoine Salmeron   +8 more
wiley   +1 more source

Therapeutic options for patients with obstructive sleep apnoea: a retrospective review of difficult-to-treat cases in a multidisciplinary approach. [PDF]

open access: yesBMJ Open Respir Res
Ho OSH   +8 more
europepmc   +1 more source

Selecting between pharmacotherapy and bariatric surgery in East Asia

open access: yes
Journal of Diabetes Investigation, EarlyView.
Yamato Keidai   +4 more
wiley   +1 more source

Annual Versus Patient‐Initiated Follow‐Up in Sleep Apnoea Care: A Quasi‐Experimental Study

open access: yesJournal of Sleep Research, EarlyView.
ABSTRACT Obstructive sleep apnoea affects nearly 1 billion people worldwide, placing increasing pressure on healthcare systems. Continuous positive airway pressure (CPAP) therapy is often the standard treatment, and efficient follow‐up strategies are needed to maintain adherence and optimise hospital resources. This study aimed to evaluate whether CPAP
Karin Jeppesen   +8 more
wiley   +1 more source

Continuous Positive Airway Pressure Versus Mandibular Advancement Devices Impact on Cardio‐Metabolic Outcomes in Patients With Obstructive Sleep Apnea: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials

open access: yesJournal of Sleep Research, EarlyView.
ABSTRACT Obstructive sleep apnea contributes to cardiovascular morbidity, and its treatment may mitigate this risk. Continuous positive airway pressure and mandibular advancement devices are established therapies, but their comparative cardiometabolic effects remain uncertain.
AlMothana Manasrah   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy